GHIMENTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 6.849
EU - Europa 3.725
AS - Asia 3.663
SA - Sud America 572
Continente sconosciuto - Info sul continente non disponibili 263
AF - Africa 192
OC - Oceania 25
Totale 15.289
Nazione #
US - Stati Uniti d'America 6.648
IT - Italia 1.432
SG - Singapore 1.084
CN - Cina 1.049
HK - Hong Kong 494
DE - Germania 477
SE - Svezia 472
BR - Brasile 455
VN - Vietnam 324
BG - Bulgaria 225
FR - Francia 208
FI - Finlandia 197
GB - Regno Unito 191
CA - Canada 149
TR - Turchia 140
IN - India 133
RU - Federazione Russa 110
JP - Giappone 108
AT - Austria 101
KR - Corea 83
CI - Costa d'Avorio 71
UA - Ucraina 51
NL - Olanda 47
BD - Bangladesh 39
PL - Polonia 34
AR - Argentina 28
ES - Italia 28
CH - Svizzera 25
IQ - Iraq 25
BE - Belgio 23
SN - Senegal 23
IR - Iran 22
ZA - Sudafrica 22
ID - Indonesia 20
AU - Australia 19
MA - Marocco 19
UZ - Uzbekistan 19
GR - Grecia 17
IE - Irlanda 17
MX - Messico 17
PK - Pakistan 17
CO - Colombia 16
EC - Ecuador 16
VE - Venezuela 16
UY - Uruguay 13
TW - Taiwan 12
CZ - Repubblica Ceca 11
MY - Malesia 11
PH - Filippine 11
SA - Arabia Saudita 11
CL - Cile 10
KE - Kenya 10
NG - Nigeria 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 9
TN - Tunisia 9
EG - Egitto 8
HU - Ungheria 8
JO - Giordania 8
IL - Israele 7
PE - Perù 7
PY - Paraguay 7
HN - Honduras 6
LB - Libano 6
MK - Macedonia 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
RO - Romania 6
DK - Danimarca 5
LT - Lituania 5
AZ - Azerbaigian 4
BY - Bielorussia 4
EE - Estonia 4
ET - Etiopia 4
NP - Nepal 4
QA - Qatar 4
AO - Angola 3
BO - Bolivia 3
CR - Costa Rica 3
GE - Georgia 3
GT - Guatemala 3
PA - Panama 3
PS - Palestinian Territory 3
SI - Slovenia 3
TH - Thailandia 3
AL - Albania 2
BB - Barbados 2
BJ - Benin 2
GA - Gabon 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LY - Libia 2
OM - Oman 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
AM - Armenia 1
Totale 15.007
Città #
Ashburn 794
Singapore 611
San Jose 501
Dallas 488
Hong Kong 481
Chandler 419
Santa Clara 367
Woodbridge 366
Fairfield 347
Serra 335
Ann Arbor 286
Beijing 245
Milan 217
Shanghai 210
Sofia 197
Houston 187
New York 182
Council Bluffs 160
Los Angeles 145
Wilmington 135
Seattle 134
Princeton 115
Boardman 110
Cambridge 110
Tokyo 95
Munich 93
Frankfurt am Main 88
Helsinki 87
Florence 84
Hefei 83
Lawrence 82
Pisa 81
Lauterbourg 77
Ottawa 75
Seoul 74
Abidjan 71
Livorno 70
Ho Chi Minh City 69
Medford 68
Hanoi 67
Vienna 67
Izmir 66
Rome 53
Ogden 50
Bremen 49
Redwood City 48
Des Moines 47
Buffalo 46
Nanjing 46
Jacksonville 43
Dong Ket 40
Lancaster 37
Turku 37
São Paulo 35
Istanbul 34
Orem 31
Redondo Beach 30
San Diego 28
Marseille 27
Nanchang 27
London 26
Atlanta 25
Pune 25
Paris 24
Nuremberg 23
Warsaw 23
Dakar 22
Boulder 21
Chennai 21
Dearborn 21
Lappeenranta 21
Amsterdam 20
Chicago 20
Plovdiv 20
Brussels 19
Hyderabad 19
Montreal 18
San Francisco 18
Brooklyn 17
Norwalk 16
Toronto 16
Lucca 15
Rio de Janeiro 15
Tashkent 15
Vancouver 15
Bern 14
Da Nang 13
Dublin 13
Haiphong 13
Kunming 13
Washington 13
Boston 12
Jiaxing 12
Nürnberg 12
Fuzhou 11
Palermo 11
Auburn Hills 10
Changsha 10
Düsseldorf 10
Montevideo 10
Totale 9.919
Nome #
Breath Analysis: Analytical Methodologies and Clinical Applications 300
A breath sampling system assessing the influence of respiratory rate on exhaled breath composition 299
A snow/firn four-century record of polycyclic aromatic hydrocarbons (PAHs) and polychlorobiphenyls (PCBs) at Talos Dome (Antarctica). 285
Using labelled internal standards to improve needle trap micro-extraction technique prior to gas chromatography/mass spectrometry 277
MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation 272
Release of harmful volatile organic compounds (VOCs) from photo-degraded plastic debris: A neglected source of environmental pollution 257
Determination of salivary alpha-amylase and cortisol in psoriatic subjects undergoing the Trier Social Stress Test 246
A dual mode breath sampler for the collection of the end-tidal and dead space fractions 242
Potentiometric sensor for non invasive lactate determination in human sweat 240
Comparison of sampling bags for the analysis of volatile organic compounds in breath 231
Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure 230
The effect of sampling procedures on the urate and lactate concentration in oral fluid 228
The Removal of β2-Microglobulin in Spent Dialysate Cannot Be Monitored by Spectrophotometric Analysis 222
A four century firn record of PAHs and PCBs at Talos Dome, Victoria Land (Antartica) 220
Determination of volatile organic compounds in exhaled breath of heart failure patients by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry 216
Determination of carbonyl compounds in exhaled breath by on-sorbent derivatization coupled with thermal desorption and gas chromatography-tandem mass spectrometry 210
Multi-Analytical Approach to Characterize the Degradation of Different Types of Microplastics: Identification and Quantification of Released Organic Compounds 208
Effects of long-term vegan diet on breath composition 207
Spatial and temporal trends of organic pollutants in Antarctica 204
Uric acid is the major determinant of absorbance in spent dialysate allowing spectrophotometric evaluation of dialysis dose 204
Micro-extraction by packed sorbent combined with UHPLC-ESI-MS/MS for the determination of prostanoids and isoprostanoids in dried blood spots 200
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 196
Determination of biomarkers in oral fluid for monitoring heart failure patients 195
Determination of volatile organic compounds in human breath for monitoring heart failure patients 190
SALIVA AS A TOOL FOR MONITORING OXIDATIVE STRESS IN SWIMMERS ATHLETES PERFORMING A VO2 CYCLE ERGOMETER TEST 189
Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study 187
Monitoring breath during oral glucose tolerance tests 186
Saliva sampling: Methods and devices. An overview 183
Determination of sevoflurane and isopropyl alcohol in exhaled breath by thermal desorption gas chromatography-mass spectrometry for exposure assessment of hospital staff 181
Monitoraggio non invasivo di terapie anticoagulanti orali 179
Influence of sampling on the determination of warfarin and warfarin alcohols in oral fluid 179
Analysis of isoprostanes in oral fluid using micro extraction by packed sorbent coupled to liquid chromatography-tandem mass spectrometry to monitor oxidative stress in healthy adults performing physical activity 177
Saliva as a non-invasive tool for monitoring oxidative stress in swimmers athletes performing a VO2max cycle ergometer test 174
Sampling bags for breath analysis 172
A non-invasive approach for monitoring patients undergoing anticoagulant therapy 172
Predicting Heart Failure Patient Events by Exploiting Saliva and Breath Biomarkers Information 172
Estimation of Heart Failure Patients Medication Adherence through the Utilization of Saliva and Breath Biomarkers and Data Mining Techniques 169
A computational approach for the estimation of heart failure patients status using saliva biomarkers 168
Type-specific inflammatory responses of vascular cells activated by interaction with virgin and aged microplastics 168
Caratterizzazione chimica dell'espirato umano in pazienti affetti da diabete mediante GC/MS 165
Pervasive sensors for real time monitoring 164
DETERMINATION OF BIOMARKERS IN BREATH AND SALIVA FOR MONITORING HEART FAILURE PATIENTS 163
Aspetti metodologici del campionamento dell’espirato 162
Post-operative elimination of sevoflurane anesthetic and hexafluoroisopropanol metabolite in exhaled breath:pharmacokinetic models for assessing liver function 162
Measurement of Warfarin in the Oral Fluid of Patients Undergoing Anticoagulant Oral Therapy 158
Diet and other factors affecting the variability of breath composition 158
A low-cost internal standard loader for solid-phase sorbing tools 153
Determination of carbonyl compounds in exhaled breath by on-sorbent derivatization coupled with thermal desorption and gas chromatography-tandem mass spectrometry 152
Development of a high-throughput liquid chromatography-tandem mass spectrometry platform for the determination of intact natriuretic peptides in human plasma 151
Salivary lactate and 8-isoprostaglandin F2α as potential non-invasive biomarkers for monitoring heart failure: a pilot study 150
A purge and trap method for the analysis of volatile organic compounds in human oral fluid 149
Spectrophotometric measurement of uric acid in spent dialysate for estimating dialysis dose 147
Determination of anticoagulant drugs and their metabolites in oral fluid and plasma samples by HPLC-Fluorimetry 147
Using labelled internal standards to improve needle trap micro-extraction technique prior to gas chromatography/mass spectrometry 142
SALIVA AS A TOOL FOR MONITORING OXIDATIVE STRESS IN SWIMMERS ATHLETES PERFORMING A VO2 CYCLE ERGOMETER TEST 142
A non-invasive approach for monitoring patients undergoing anticoagulant therapy 140
May oral fluid analysis complement INR assay in the prevention of adverse events? 136
Saliva tests: application to drug and health care monitoring 135
Biological studies with comprehensive 2D-GC-HRMS screening: Exploring the human sweat volatilome 133
Micro extraction by packed sorbent coupled to liquid chromatography-tandem mass spectrometry for the analysis of prostanoids and isoprostanoids in dried blood spots of preterm newborns suffering from patent ductus arteriosus 133
Methodological aspects of dried blood spot sampling for the determination of isoprostanoids and prostanoids 133
Breath analysis combined with cardiopulmonary exercise testing and echocardiography for monitoring heart failure patients: the AEOLUS protocol 132
Effect of sampling procedures for the chemical characterization of oral fluid in clinical applications 130
Monitoring of warfarin therapy by saliva analysis: an open issue on the way to clinical practice 128
Salivary lipid mediators: Key indexes of inflammation regulation in heart failure disease 125
Monitoring urea, creatinine and 2-microglobulin concentrations in spent dialysate by spectrophotometric and spectrofluorimetric measurements 124
NEEDLE TRAP MICRO-EXTRACTION: A NEW STRATEGY FOR THE COLLECTION AND PRECONCENTRATION OF BREATH SAMPLES 124
THE EFFECT OF EXERCISE ON SALIVARY LACTATE, ALPHA-AMYLASE AND URIC ACID IN HEALTHY VOLUNTEERS 123
Stability of volatile organic compounds in sorbent tubes following SARS-CoV-2 inactivation procedures 123
Determination of warfarin and warfarin alcohols in dried blood spots by ultra-high performance liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS/MS) 121
Determination of volatile organic compounds in exhaled breath of heart failure patients by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry 121
A breath sampler prototype to collect end-tidal and dead space fractions 119
Development of an Analytical Procedure for the Quantification of Volatile Compounds in Human Breath 119
Determination of peppermint compounds in breath by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry 119
Determination of anticoagulant drugs and their metabolites in oral fluid: strategies for sample collection 116
Spectrophotometric and spectrofluorimetric analysis of spent dialysate should allow monitoring of dialysis adequacy even if urea concentrations cannot be determined by these methods 115
Influence of sampling on the measured concentration of warfarin and warfarin alcohols in oral fluid 115
Determination of warfarin and warfarin alcohols in oral fluid and plasma samples for monitoring patients undergoing anticoagulant therapy 111
Correlation between warfarin salivary concentration and anticoagulant effect 109
Determination of bound and unbound warfarin and its metabolites in human plasma 108
Sport in town: The smart healthy env project, a pilot study of physical activity with multiparametric monitoring 107
Volatile Compounds in Human Breath During Oral Glucose Tolerance Test 106
Correlazione tra contenuto salivare di farmaci anticoagulanti in pazienti trombotici ed effetto anticoagulante 104
Advances in breath and saliva analysis 104
Decoding the Challenges: navigating Intact Peptide Mass Spectrometry-Based Analysis for Biological Applications 103
Pharmacokinetic models of post-operative elimination of sevoflurane anesthetic and hexafluoroisopropanol metabolite as measured in exhaled breath 102
Determination of volatile organic compounds in human breath samples for heart failure monitoring 101
Determinazione del warfarin in campioni di saliva e plasma raccolti da pazienti in terapia anticoagulante 95
A MEPS-UHPLC-MS/MS analytical platform to detect isoprostanoids and specialized pro-resolving mediators in the urinary extracellular vesicles of mountain ultramarathon runners 94
A sampler prototype for the simultaneous collection of exhaled air and breath condensate 94
null 89
The effect of SARS-CoV-2 variants on the plasma oxylipins and PUFAs of COVID-19 patients 88
Monitoring urea, creatinine and 2-microglobulin concentrations in spent dialysate by spectrophotometric and spectrofluorimetric measurements 85
null 69
Determination of volatile organic compounds in human breath samples for heart failure monitoring 67
Dried blood spot analysis of long-chain polyunsaturated fatty acids and oxylipins for monitoring heart failure 53
HiSorb sorptive extraction for determining salivary short chain fatty acids and hydroxy acids in heart failure patients 36
Totale 15.289
Categoria #
all - tutte 43.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.036 0 56 26 58 160 120 40 66 37 47 117 309
2022/20231.535 194 239 119 172 124 170 12 102 276 17 93 17
2023/20241.128 92 94 133 72 134 191 57 38 35 74 80 128
2024/20253.291 42 108 66 189 219 336 397 169 303 415 410 637
2025/20264.140 247 467 532 356 433 376 609 201 256 483 122 58
2026/2027310 117 193 0 0 0 0 0 0 0 0 0 0
Totale 15.289